Magenta Medical
Treatment for Acute Hearth Failure
Magenta Medical has raised €13M across 1 funding round from 3 investors, most recently a Series B round in Aug 2017. Based in Israel; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€13M
€12,790,995
Funding rounds
1
Investors
3
distinct backers
Active since
2017-08
latest 2017-08
Funding by year
EUR raised per yearMagenta Medical — funding by year — interactive chart.
Data table
| Magenta Medical — funding by year | |
|---|---|
| 2017 | €13M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-08-01 | Series B | €13M | Abiomed,JAFCO Japan,Pitango Venture Capital | View deal → |
Related news
Similar companies
same sector, similar size- Biond Biologics€15MIsrael · Healthtech
- MediSafe€18MIsrael · Healthtech
- ImmunArray€9.1MIsrael · Healthtech
- MDClone€13MIsrael · Healthtech
- Belkin Laser€15MIsrael · Healthtech
- EyeYon Medical€6.5MIsrael · Healthtech
Global coverage: FundingData